Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands
Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands
Recruiting · NCT06685978 · Registry updated 2024-11-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands | Hyperplasia of Mammary Glands | Recruiting | Phase 3 | 2024-11-13 | NCT06685978 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tasly Pharmaceutical Group Co., Ltd | 16 |
27 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.